The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.

Interleukin 1 (IL-1) is a 17 kDa protein highly conserved through evolution and is a key mediator of inflammation, fever and the acute-phase response. IL-1 has important functions in the innate ...

Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting interleukin (IL)-12, IL-23, or IL-17 were associated with a lower rate of serious ...

They achieved this by developing sucralfate microneedles (SUC-MN) to deliver an important immunomodulatory protein, interleukin-4 (IL-4), to stimulate the production of growth factors in diabetic ...

This approval is the fourth indication for this dual-acting interleukin-23 inhibitor in the ... Tremfya (400 mg subcutaneous induction at weeks 0, 4, and 8) led to significantly higher clinical ...